β-catenin as a diagnostic marker and therapeutic target for the treatment of Type I diabetes

被引：0
|
作者：
Zirnheld, Arin [1 ]
Parnell, Sarah [1 ]
Kosiewicz, Michele [1 ]
Alard, Pascale [1 ]
机构：
[1] Univ Louisville, Louisville, KY 40292 USA
来源：
JOURNAL OF IMMUNOLOGY | 2011年 / 186卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
101.33
引用
收藏
页数：2
相关论文
共 50 条
  • [1] DNA methylation as a diagnostic and therapeutic target in the battle against Type 2 diabetes
    Ronn, Tina
    Ling, Charlotte
    EPIGENOMICS, 2015, 7 (03) : 451 - 460
  • [2] α-Synuclein as a Diagnostic Marker and Therapeutic Target for Parkinson Disease
    Luan Ming-Yue
    Wang Zhao-Xia
    Deng Jian-Wen
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2022, 49 (01) : 86 - 99
  • [3] Mammaglobin A as a diagnostic marker and therapeutic target in breast cancer
    Lisiak, Natalia
    Sierszulska, Maria
    Bajsert, Julia
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2020, 74 : 566 - 571
  • [4] Microalbuminuria in Type 2 Diabetes and Hypertension A marker, treatment target, or innocent bystander?
    Basi, Seema
    Fesler, Pierre
    Mimran, Albert
    Lewis, Julia B.
    DIABETES CARE, 2008, 31 : S194 - S201
  • [5] Neutrophil elastase as a diagnostic marker and therapeutic target in colorectal cancers
    Ho, Ai-Sheng
    Chen, Chien-Hsin
    Cheng, Chun-Chia
    Wang, Chia-Chi
    Lin, Hua-Ching
    Luo, Tsai-Yueh
    Lien, Gi-Shih
    Chang, Jungshan
    ONCOTARGET, 2014, 5 (02) : 473 - 480
  • [6] Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention
    Hermida, Ramon C.
    Ayala, Diana E.
    Mojon, Artemio
    Fernandez, Jose R.
    DIABETOLOGIA, 2016, 59 (02) : 244 - 254
  • [7] Sleep-time BP: prognostic marker of type 2 diabetes and therapeutic target for prevention
    Ramón C. Hermida
    Diana E. Ayala
    Artemio Mojón
    José R. Fernández
    Diabetologia, 2016, 59 : 244 - 254
  • [8] Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 Diabetes
    Burant, Charles F.
    DIABETES CARE, 2013, 36 : S175 - S179
  • [9] Type 2 diabetes: ceramides as a therapeutic target?
    Hajduch, Eric
    Bourron, Olivier
    CLINICAL LIPIDOLOGY, 2013, 8 (06) : 607 - 609
  • [10] Adiponectin as a Marker of Complications in Type I Diabetes
    Habeeb, Nevin Mohamed Mamdouh
    Youssef, Omneya Ibrahim
    Saab, Azza Abdel Rahman
    El Hadidi, Eman Saleh
    INDIAN PEDIATRICS, 2012, 49 (04) : 277 - 280
12345